Sudarshan Pharma Industries, founded in 2008, offers over 50 pharmaceutical formulations under their brand name, including tablets, ointments, and injectables.
Sudarshan Pharma sectors core business is to manufacture specialty chemicals and ingredients for the pharmaceutical, agrochemical, coating, paint, adhesive, and other sectors. SPIL is active in contract manufacturing, outsourcing, and supplying generic pharmaceutical formulations and medications to healthcare institutions, governments, non-governmental organizations (NGOs), and hospitals.
Sudarshan Pharma Industries Ltd. IPO Objective
- The IPO funds are primarily required to be spent on meeting working capital requirements and general corporate purposes.
Why should you invest in Sudarshan Pharma Industries Ltd. IPO?
Here are your top three reasons to consider investing in the IPO:
- Their product offering is extensive, including specialized chemicals, bulk medicines, APIs, and pharmaceutical formulations.
- Their major international clients come from Taiwan, Oman, Uzbekistan, Bangladesh, UK and others.
- The company is growing by opening a cutting-edge manufacturing facility and increasing distributor networks and logistical infrastructure in the five Indian states it serves.
Sudarshan Pharma Industries Company Financials
|Parameters||Period Ending on September 30, 2022 (₹ Lakhs)||Year ending on 31st March, 2022 (₹ Lakhs)||Year ending on 31st March, 2021 (₹ Lakhs)|
|Revenue from operation||19,589.87||35,709.46||19,335.03|
|Profit After Tax||360.70||530.37||267.12|
|Period Ended||Year ending on As on 31st March, 2022||Year ending on As on 31st March, 2021||Year ending on As on 31st March, 2020|
Know before investing
Sudarshan Pharma Industries Ltd. Noteworthy highlights
- Their portfolio includes 2000+ products in specialty chemicals, Intermediates for pharma, agrochemicals, paints, adhesives and other industrial chemicals.
- The company is exploring new markets with new products in Africa, Southeast Asia, and the MENA region.
Sudarshan Pharma Industries IPO FAQs:
Q1. What is Sudarshan Pharma Industries Ltd. IPO?
Ans. Sudarshan Pharma Industries Ltd. SME IPO will open for subscription on March 9, 2023. The public offer of ₹50.10 crore consists of 6,862,400 equity shares with a face value of ₹10.
Q2. When will Sudarshan Pharma Industries Ltd. IPO allotment be available?
Ans. The basis of the allotment date is March 17, 2023.
Q3. What will be the Sudarshan Pharma Industries Ltd. IPO lot size?
Ans. One lot of Sudarshan Pharma Industries Ltd. IPO has 1600 shares.
Q4. When will Sudarshan Pharma Industries Ltd. IPO open for subscription?
Ans. The IPO will open on March 9, 2023.
Q5. What minimum lot size can retail investors subscribe to?
Ans. Retail investors can apply for a minimum of one lot.
Q6. When will Sudarshan Pharma Industries Ltd. list on exchanges?
Ans. The listing date of Sudarshan Pharma Industries Limited on BSE SME is March 22, 2023.
Q7. What would be the listing gains on the Sudarshan Pharma Industries Ltd. IPO?
Ans. Listing gain is the difference between the IPO’s opening and offer prices. The listing gain is influenced by changing investors’ interests, global parameters, and short and long-term outlooks.
Q8. I have finished the application process for Sudarshan Pharma Industries Ltd. IPO, but the funds are not yet debited. What is the reason?
Ans. The bank initially blocks the amount you bid for an IPO. It will debit the money when the shares are allotted or unblock the amount after the UPI mandate expiry date.
Q9. How do I approve the UPI mandate request for Sudarshan Pharma Industries Ltd. IPO?
Ans. Login to your UPI handle and approve the payment mandate to complete the IPO application process.
Q10. Can I submit more than one application for the public issue of Sudarshan Pharma Industries Ltd. using one PAN?
Ans. You can submit only one application using one PAN card.
Q11. What is the minimum order quantity for Sudarshan Pharma Industries Ltd. IPO?
Ans. The minimum size of the application will be one lot of 1600 shares.